Effect of Add-On Semaglutide vs Sitagliptin for Type 2 Diabetes, Doxepin vs Standard Mouthwash for XRT-Related Mucositis, Workplace Wellness Programs for Employee Health, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the April 16, 2019 issue
Source: JAMA: This Week's Audio Commentary - Category: General Medicine Authors: JAMA Network Source Type: podcasts
More News: American Medical Association (AMA) | Diabetes | Diabetes Type 2 | Doxepin | Endocrinology | General Medicine | Januvia